CD274 and collecting duct carcinoma: Recent studies have revealed an increased expression of programmed death ligand 1 (PD-L1) in CDC cells and reported partial efficacy of immune checkpoint inhibitors, such as anti-programmed death 1 (PD-1) and cytotoxic T-lymphocyte antigen 4, in CDC treatment [4, 5].